PHLARE PRECISE HLA DIRECTING ENGAGERS Trademark
Trademark Overview
On Thursday, June 20, 2024, a trademark application was filed for PHLARE PRECISE HLA DIRECTING ENGAGERS with the United States Patent and Trademark Office. The USPTO has given the PHLARE PRECISE HLA DIRECTING ENGAGERS trademark a serial number of 98611242. The federal status of this trademark filing is PRIORITY ACTION MAILED as of Tuesday, January 14, 2025. This trademark is owned by Clasp Therapeutics, Inc.. The PHLARE PRECISE HLA DIRECTING ENGAGERS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
pharmaceutical preparations for the prevention and treatment of cancer; chemical and biochemical preparations and substances for medical purposes for the prevention and treatment of cancer; biological preparations for the prevention and treatment of cancer
pharmaceutical drug development services; scientific research; pharmaceutical research services; research and development in the pharmaceutical and biotechnology fields
General Information
| Serial Number | 98611242 |
| Word Mark | PHLARE PRECISE HLA DIRECTING ENGAGERS |
| Filing Date | Thursday, June 20, 2024 |
| Status | 658 - PRIORITY ACTION MAILED |
| Status Date | Tuesday, January 14, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Description of Mark | The mark consists of the word "phlare" located above the phrase "Precise HLA Redirecting Engagers". |
| Goods and Services | pharmaceutical preparations for the prevention and treatment of cancer; chemical and biochemical preparations and substances for medical purposes for the prevention and treatment of cancer; biological preparations for the prevention and treatment of cancer |
| Pseudo Mark | FLARE PRECISE HLA DIRECTING ENGAGERS; FLAIR PRECISE HLA DIRECTING ENGAGERS; PHLAIR PRECISE HLA DIRECTING ENGAGERS |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | pharmaceutical drug development services; scientific research; pharmaceutical research services; research and development in the pharmaceutical and biotechnology fields |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 20, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 20, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Clasp Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Rockville, MD 20850 |
Trademark Events
| Event Date | Event Description |
| Thursday, June 20, 2024 | NEW APPLICATION ENTERED |
| Monday, January 13, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, January 14, 2025 | PRIORITY ACTION WRITTEN |
| Tuesday, January 14, 2025 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Tuesday, January 14, 2025 | PRIORITY ACTION E-MAILED |
| Tuesday, January 14, 2025 | ASSIGNED TO EXAMINER |
